🇺🇸 FDA
Patent

US 8017781

Azaindazoles useful as inhibitors of kinases

granted A61PA61P11/06A61P19/08

Quick answer

US patent 8017781 (Azaindazoles useful as inhibitors of kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P11/06, A61P19/08, A61P25/00, A61P25/28